Orbactive Co-promote cancelled due to Pfizer bid process

Discussion in 'Forest Laboratories' started by Anonymous, Sep 16, 2014 at 12:10 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Partnership "OFF the table"! Per the conf call of The Med Co. no Actavis co-promote due to Pfizer bid on buyout. They launch October 1st. Price of $2,900 undercutting Durata big time. We expect mass departures at Forest and upper mgmt's opinion is pretty much "who cares that's less severance for us to pay". Also know that bacteremia is very delayed due to the need of more data. You will see some big people jumping ship very soon.
     

  2. Anonymous

    Anonymous Guest

    Hopefully Quinn jumps ship and jumps right into an iceberg. Selling - find the need ... .....ugggh..
     
  3. Anonymous

    Anonymous Guest

    well that's it...we're hosed. Come on Pfizer, give us our severances
     
  4. Anonymous

    Anonymous Guest

    What bid process? Nothing has happened yet. Pfizer is interested in AZ.
     
  5. Anonymous

    Anonymous Guest

    You have some reading to catch up on.
     
  6. Anonymous

    Anonymous Guest

    Oh, hi Quinn guy! You're back. Nice to see you again.
     
  7. Anonymous

    Anonymous Guest

    This is absolutely true! At least about the co-promote being off the table. Medicines Co. managers already calling Forest reps again recruiting them over.